Despite the important role of the NGF/TrkA axis in tumor metastasis, researchers have yet to identify the specific molecular mechanisms by which it acts on osteosarcoma or the effectiveness of larotrectinib in this context. The gene discussed is NTRK1; the disease is neoplasm.